Author

Chih‐Ling Kuo

Observed name: Chih-Ling Kuo

Observed institution: National Yang Ming University

OpenAlex ID: A5001102824

Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma

2024 · Peter W. Szlosarek, Benjamin C. Creelan, et al. · JAMA Oncology · 60

Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer

2021 · Peter W. Szlosarek, Akhila G. Wimalasingham, et al. · Cancer Medicine · 18

Phase IB trial of pegylated arginine deiminase (ADI-PEG 20) plus radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.

2022 · John S. Bomalaski, Ko-Ting Chen, et al. · Journal of Clinical Oncology · 9

Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.

2021 · Brian Andrew Van Tine, Angela C. Hirbe, et al. · Journal of Clinical Oncology · 9

Construction of endophenotypes for complex diseases in the presence of heterogeneity

2005 · Chien-Hsiun Chen, Chih-Ling Kuo, et al. · BMC Genetics · 2

Works count: 5

Citation count: 98

H-index: 4

I10-index: 2